This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Complications of genitourinary prosthetic devices, implants and grafts
ST19_COMPLICATIO_GENITO_PROSTHET_DEVICES_IMPLANTS_GRAFTS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
919 |
4. Check minimum number of eventsNone |
919 |
5. Include endpointsNone |
919 |
6. Filter based on genotype QC (FinnGen only) |
919 |
Control definitions (FinnGen only)
- Control exclude
- ST19_COMPLICATIO_SURGI_MEDICAL_CARE_NOT_ELSEW_CLASSIFIED
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- T8
- Name in latin
- Complicationes mechanismorum, implantatorum et transplantatorum urogenitalium
Similar endpoints
↥List of similar endpoints to
Complications of genitourinary prosthetic devices, implants and grafts
based on the number of shared cases.
Similar with more cases:
- Complications of surgical and medical care, not elsewhere classified
- Injury, poisoning and certain other consequences of external causes
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 919 | 625 | 294 |
| Unadjusted period prevalence (%) | 0.19 | 0.21 | 0.13 |
| Median age at first event (years) | 58.67 | 52.15 | 72.54 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 831
- Matched controls
- 8308
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
247.3
261.6
257
15
T83.0
ICD-10 Finland
Mechanical complication of urinary (indwelling) catheter
2667.7
233.7
215
*
T83.8
ICD-10 Finland
Other complications of genitourinary prosthetic devices, implants and grafts
+∞
203.8
187
*
T83.3
ICD-10 Finland
Mechanical complication of intrauterine contraceptive device
2392.6
192.4
179
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
48.3
124.3
151
38
UKC02
NOMESCO Finland
Cystoscopy
6.4
100.1
315
723
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
184.8
95.5
98
6
R33
ICD-10 Finland
Retention of urine
9.0
91.3
211
303
T83.1
ICD-10 Finland
Mechanical complication of other urinary devices and implants
+∞
88.1
83
*
LWW96
NOMESCO Finland
Other reoperation in gynaecological surgery
+∞
85.9
81
*
T83.4
ICD-10 Finland
Mechanical complication of other prosthetic devices, implants and grafts in genital tract
+∞
83.8
79
*
Y83.1
ICD-10 Finland
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
+∞
82.7
78
*
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
432.4
80.4
79
*
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
821.4
77.6
75
*
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
7.8
77.2
195
315
N39.3
ICD-10 Finland
Stress incontinence
7.7
71.0
179
286
JAL11
NOMESCO Finland
Laparoscopy and removal of foreign body
+∞
56.9
54
*
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
94.0
55.7
61
7
T83.9
ICD-10 Finland
Unspecified complication of genitourinary prosthetic device, implant and graft
+∞
53.7
51
*
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
22.8
50.2
73
35
J01MA02
ATC
ciprofloxacin; systemic
3.1
50.1
423
2092
LEG10
NOMESCO Finland
Vaginal urethrocystopexy
12.6
49.1
90
79
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
177.1
48.4
50
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.9
45.5
215
675
R31
ICD-10 Finland
Unspecified haematuria
4.8
45.3
167
413
TKC20
NOMESCO Finland
Catheterisation of bladder
5.7
45.1
140
285
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
4.2
44.2
192
557
T83.6
ICD-10 Finland
Infection and inflammatory reaction due to prosthetic device, implant and graft in genital tract
+∞
44.2
42
*
J01EA01
ATC
trimethoprim; systemic
3.1
44.0
323
1419
WX408
NOMESCO Finland
General anesthesy, balanced
3.2
43.8
296
1225
N39.4
ICD-10 Finland
Other specified urinary incontinence
4.8
38.7
141
341
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.8
37.9
315
1467
N81.6
ICD-10 Finland
Rectocele
4.9
34.8
121
277
LEF03
NOMESCO Finland
Posterior colporrpahy with sutures for primary rectocele
7.1
34.7
88
136
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.8
34.3
161
491
N81.1
ICD-10 Finland
Cystocele
5.1
34.1
115
254
Z43.5
ICD-10 Finland
Attention to cystostomy
52.4
33.8
40
8
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
23.1
33.4
48
22
Y60
ICD-10 Finland
Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care
121.7
32.9
35
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
5.6
32.4
99
195
N99.3
ICD-10 Finland
Prolapse of vaginal vault after hysterectomy
11.9
32.3
60
54
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
118.0
31.9
34
*
N30.0
ICD-10 Finland
Acute cystitis
3.3
31.8
183
654
LEG12
NOMESCO Finland
Transobturatoric tape
13.3
31.7
56
45
T81.9
ICD-10 Finland
Unspecified complication of procedure
166.2
30.9
32
*
XKC03
NOMESCO Finland
Water cystometry
7.8
29.6
70
97
ZXD05
NOMESCO Finland
Urgent procedure
2.5
29.4
313
1629
J01MA12
ATC
levofloxacin; systemic
2.9
29.1
211
877
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
155.4
28.8
30
*
LWL03
NOMESCO Finland
Gynaecological prolapse mesh revision surgery
+∞
28.3
27
*
U05
ICPC
Urination problems other
5.7
26.8
80
153
XKD06
NOMESCO Finland
Physiologic investigation of micturition
7.5
26.4
64
92
XKD00
NOMESCO Finland
Uroflowmetry
3.0
26.0
166
629
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
96.5
25.8
28
*
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
45.9
25.7
31
7
LEF53
NOMESCO Finland
Vaginal colpopexy after previous hysterectomy
26.0
25.4
35
14
XKD03
NOMESCO Finland
Urethral pressure profilometry
9.1
25.4
54
63
KA3EB
NOMESCO Finland
Antegrade pyelography
31.2
25.2
33
11
R32
ICD-10 Finland
Unspecified urinary incontinence
7.8
25.1
59
81
N30.9
ICD-10 Finland
Cystitis, unspecified
4.7
24.9
88
203
N81.5
ICD-10 Finland
Vaginal enterocele
9.6
24.3
50
55
WX320
NOMESCO Finland
Spinalanesthesy
2.5
24.2
226
1073
J01DB01
ATC
cefalexin; oral
2.5
23.6
694
5579
N02BE01
ATC
paracetamol; systemic, rectal
2.8
23.5
734
6094
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
3.3
23.5
130
444
U29
ICPC
Urinary symptom/complaint other
7.5
23.0
55
78
SPAT1167
SPAT
Insertion of urinary catheter
6.7
22.9
59
93
U07
ICPC
Urine symptom/complaint other
4.3
22.8
88
222
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.9
22.7
65
118
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
22.6
331
1945
Y84.9
ICD-10 Finland
Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
+∞
22.0
21
*
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
39.8
21.8
27
7
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
21.5
328
1954
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.8
21.2
153
622
B01AB05
ATC
enoxaparin; parenteral
2.2
20.5
270
1498
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.1
20.5
120
425
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
15.6
20.4
33
22
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.3
20.3
223
1136
X59
ICD-10 Finland
Exposure to unspecified factor
2.6
20.0
161
696
T83.5
ICD-10 Finland
Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system
+∞
19.9
19
*
T83.2
ICD-10 Finland
Mechanical complication of graft of urinary organ
+∞
19.9
19
*
A06AD11
ATC
lactulose; oral
2.7
19.8
149
619
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
107.6
19.6
21
*
Y88.1
ICD-10 Finland
Sequelae of misadventures to patients during surgical and medical procedures
204.7
19.6
20
*
A28
ICPC
Limited function/disability NOS
2.7
19.6
153
649
JN3AD
NOMESCO Finland
Abdominal CT examination
3.7
19.4
90
267
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
7.9
18.8
43
57
N03AX16
ATC
pregabalin; oral
2.2
18.5
216
1129
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
18.4
192
949
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
18.1
18.3
28
16
WX002
NOMESCO Finland
Sedation and analgesia
2.3
18.3
187
915
Y89.9
ICD-10 Finland
Sequelae of unspecified external cause
45.1
18.3
22
5
JAH01
NOMESCO Finland
Laparoscopy
4.8
18.3
62
137
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
14.8
18.2
30
21
LEF00
NOMESCO Finland
Anterior colporraphy with sutures for primary cystocele
4.8
18.2
62
138
U08
ICPC
Urinary retention
7.9
18.0
41
54
N02AA05
ATC
oxycodone; systemic
2.6
17.6
139
593
ZXE00
NOMESCO Finland
One hour or less
1.9
17.5
351
2277
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.8
17.4
124
497
P01AB01
ATC
metronidazole; oral, rectal
1.9
17.4
353
2299
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.7
17.4
130
537
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
5.6
17.4
51
96
Z94.0
ICD-10 Finland
Kidney transplant status
12.9
17.2
30
24
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
17.1
360
2371
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
26.2
17.0
23
9
X57
ICD-10 Finland
Unspecified privation
8.7
16.9
36
43
SPAT1262
SPAT
Handing over of treatment supplies
2.3
16.8
169
818
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
16.8
129
541
R50.9
ICD-10 Finland
Fever, unspecified
2.6
16.7
133
567
T81.2
ICD-10 Finland
Accidental puncture and laceration during a procedure, not elsewhere classified
173.3
16.6
17
*
N02AX02
ATC
tramadol; systemic, rectal
1.9
16.5
348
2286
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
8.0
16.5
37
48
A41.9
ICD-10 Finland
Sepsis, unspecified
5.6
16.1
47
88
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
15.9
183
940
NFC20
NOMESCO Finland
Secondary implantation of hip prosthesis
61.2
15.8
18
*
LWK03
NOMESCO Finland
Division of urinary incontinence sling
+∞
15.7
15
*
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
+∞
15.7
15
*
G04BD12
ATC
mirabegron; oral
2.8
15.5
108
424
LEW96
NOMESCO Finland
Other operation on vagina
162.9
15.5
16
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.8
15.5
108
425
G04BD08
ATC
solifenacin; oral
3.2
15.4
84
282
TKC22
NOMESCO Finland
Catheterisation instruction
6.4
15.3
40
65
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
6.4
15.3
40
65
KA1AE
NOMESCO Finland
Kidney ultrasound examination
6.2
15.3
41
69
C03CA01
ATC
furosemide; systemic
2.0
15.2
251
1496
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
23.9
15.2
21
9
TLC00
NOMESCO Finland
Insertion of intrauterine device
3.2
15.0
80
265
KH1AT
NOMESCO Finland
Urinary tract cathetrisation with ultrasound guidance
25.6
14.7
20
8
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.8
14.6
62
171
127
Kela drug reimbursment
Transplant complication
9.3
14.3
29
32
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
14.2
134
623
G04CA02
ATC
tamsulosin; oral
2.1
14.1
181
972
N18.0
ICD-10 Finland
End-stage renal disease
13.0
14.0
24
19
U13
ICPC
Bladder symptom/complaint other
4.4
13.8
50
119
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
6.3
13.8
36
59
K59.09
ICD-10 Finland
Constipation, unspecified
3.6
13.7
62
181
WX402
NOMESCO Finland
General anaesthesia
2.3
13.6
140
680
Y84.6
ICD-10 Finland
Urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
+∞
13.6
13
*
KWW96
NOMESCO Finland
Other reoperation in urological surgery
+∞
13.6
13
*
X58
ICD-10 Finland
Exposure to other specified factors
2.6
13.6
109
464
KED22
NOMESCO Finland
Transurethral resection of prostate
3.5
13.5
64
194
Y88
ICD-10 Finland
Sequelae with surgical and medical care as external cause
142.2
13.5
14
*
U99
ICPC
Urinary disease other
18.6
13.4
20
11
L04AA06
ATC
mycophenolic acid; systemic
8.3
13.4
29
36
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
21.6
13.4
19
9
J01CA08
ATC
pivmecillinam; oral
1.7
12.9
369
2614
TLC02
NOMESCO Finland
Simple extraction of IUD
3.5
12.8
60
180
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
10.7
12.8
24
23
TK800
NOMESCO Finland
Hemodialysis
6.8
12.6
31
47
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.6
12.6
98
412
U28
ICPC
Limited function/disability (U)
8.9
12.6
26
30
KDK40
NOMESCO Finland
Removal of artificial urethral sphincter
+∞
12.5
12
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
24.7
12.5
17
7
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
24.7
12.5
17
7
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
8.2
12.4
27
34
L89
ICD-10 Finland
Decubitus ulcer and pressure area
8.2
12.4
27
34
N21.0
ICD-10 Finland
Calculus in bladder
8.6
12.3
26
31
A41.8
ICD-10 Finland
Other specified sepsis
9.2
12.3
25
28
Z49.1
ICD-10 Finland
Extracorporeal dialysis
9.9
12.3
24
25
V03AE01
ATC
polystyrene sulfonate; oral
9.9
12.3
24
25
AA1AD
NOMESCO Finland
CT of head and brain
1.9
12.3
196
1141
V03AE02
ATC
sevelamer; oral
38.1
12.2
15
*
L28
ICPC
Limited function/disability (L)
2.2
12.2
137
690
A12AA04
ATC
calcium carbonate; oral
7.1
12.2
29
42
J01MA01
ATC
ofloxacin; systemic
2.6
12.2
89
360
G04BD07
ATC
tolterodine; oral
3.3
12.2
62
199
WX110
NOMESCO Finland
Local anesthesy
1.7
12.1
540
4326
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
11.3
12.1
22
20
ULC02
NOMESCO Finland
Hysteroscopy
3.2
12.1
63
206
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.1
12.0
145
753
KCJ00
NOMESCO Finland
Cystostomy
47.4
11.9
14
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
5.0
11.9
37
76
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.8
11.8
225
1392
M54.5
ICD-10 Finland
Low back pain
1.8
11.7
265
1731
KDK10
NOMESCO Finland
Implantation of artificial urinary sphincter around bulbar urethra
65.9
11.6
13
*
LGA22
NOMESCO Finland
Hysteroscopic sterilisation
7.3
11.6
27
38
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
8.8
11.6
24
28
A02BC02
ATC
pantoprazole; systemic
1.7
11.5
512
4066
U06
ICPC
Haematuria
5.2
11.5
35
70
Z43.6
ICD-10 Finland
Attention to other artificial openings of urinary tract
+∞
11.5
11
*
Y65.8
ICD-10 Finland
Other specified misadventures during surgical and medical care
121.6
11.5
12
*
Z93.5
ICD-10 Finland
Cystostomy status
35.5
11.3
14
*
Z71.8
ICD-10 Finland
Other specified counselling
1.9
11.3
196
1170
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
5.8
11.3
31
55
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
11.2
316
2205
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
10.2
11.0
21
21
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
11.0
139
735
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
11.0
402
3009
ZXD20
NOMESCO Finland
Day surgery
2.2
10.9
118
584
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
43.9
10.9
13
*
N81.2
ICD-10 Finland
Incomplete uterovaginal prolapse
3.2
10.9
56
181
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
10.8
10.8
20
19
TQW11
NOMESCO Finland
Vacuum treatment of wound
9.8
10.8
21
22
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
4.7
10.8
36
80
LEF06
NOMESCO Finland
Anterior colporraphy with mesh for recurrent cystocele
18.1
10.8
16
9
N40
ICD-10 Finland
Hyperplasia of prostate
2.0
10.7
157
880
M79.6
ICD-10 Finland
Pain in limb
1.7
10.7
286
1954
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.2
10.6
111
539
N03AX12
ATC
gabapentin; oral
2.1
10.5
127
658
KCD02
NOMESCO Finland
Transurethral resection of bladder
5.7
10.5
29
52
Y60.0
ICD-10 Finland
Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care during surgical operation
+∞
10.4
10
*
UJF32
NOMESCO Finland
Coloscopy
1.8
10.4
197
1209
S97
ICPC
Chronic ulcer skin
3.3
10.4
51
160
Z3231
NOMESCO Finland
Registered nurse
1.8
10.4
224
1436
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
10.3
133
708
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
10.2
261
1759
J01FF01
ATC
clindamycin; systemic
1.8
10.1
207
1302
G04BD04
ATC
oxybutynin; oral, transdermal
2.8
10.1
64
239
J01CA04
ATC
amoxicillin; systemic
1.7
10.1
646
5568
B01AB10
ATC
tinzaparin; parenteral
2.9
10.1
60
216
Z09.9
ICD-10 Finland
Follow-up examination after unspecified treatment for other conditions
9.3
10.1
20
22
N99.8
ICD-10 Finland
Other postprocedural disorders of genitourinary system
40.6
10.0
12
*
JAL10
NOMESCO Finland
Laparotomy and removal of foreign body
40.6
10.0
12
*
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
7.8
9.9
22
29
SPAT1263
SPAT
Sampling
1.6
9.9
340
2479
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.0
9.9
58
206
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
9.9
193
1193
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
5.3
9.9
29
56
N89.8
ICD-10 Finland
Other specified noninflammatory disorders of vagina
12.4
9.9
17
14
B03XA01
ATC
erythropoietin; parenteral
8.9
9.8
20
23
N06AX21
ATC
duloxetine; oral
2.3
9.8
94
439
LEF40
NOMESCO Finland
Vaginal repair of enterocele
13.6
9.7
16
12
W19
ICD-10 Finland
Unspecified fall
2.4
9.6
81
356
LEF96
NOMESCO Finland
Other operation for prolapse of uterus or vaginal vault
11.5
9.6
17
15
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
6.1
9.6
25
42
KCF02
NOMESCO Finland
Transluminal endoscopic removal of foreign body from bladder
101.1
9.4
10
*
KCC00
NOMESCO Finland
Cystectomy
+∞
9.4
9
*
Y98
ICD-10 Finland
Lifestyle-related condition
22.0
9.4
13
6
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
9.4
72
299
KC1GB
NOMESCO Finland
Cystography with X-ray
10.8
9.3
17
16
SPAT1229
SPAT
Assessment of need for aid
2.4
9.3
76
329
TPH07
NOMESCO Finland
Cathetrisation of artery
2.4
9.3
81
363
A11CC03
ATC
alfacalcidol; systemic
4.4
9.2
32
75
WX725
NOMESCO Finland
Noninvasive ventilation
3.4
9.2
43
131
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.7
9.2
30
66
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
9.2
249
1695
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
9.2
200
1278
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.8
9.1
58
218
137
Kela drug reimbursment
Uraemia requiring dialysis
10.2
9.0
17
17
G04BD11
ATC
fesoterodine; oral
3.7
9.0
38
106
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.9
9.0
56
205
J01XX08
ATC
linezolid; systemic
37.1
9.0
11
*
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
9.0
431
3392
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.0
9.0
122
664
L04AD01
ATC
ciclosporin; systemic
5.6
9.0
25
46
ZXA00
NOMESCO Finland
Right side
1.7
8.9
210
1372
N13.9
ICD-10 Finland
Obstructive and reflux uropathy, unspecified
12.7
8.9
15
12
UKB02
NOMESCO Finland
Retrograde ureteroscopy
8.1
8.9
19
24
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
8.7
8.8
18
21
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
8.7
8.8
18
21
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
8.8
224
1496
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.7
8.8
59
228
R11
ICD-10 Finland
Nausea and vomiting
2.4
8.7
74
326
NFH30
NOMESCO Finland
Reduction of dislocation prosthesis of hip joint, closed
50.5
8.7
10
*
N99.5
ICD-10 Finland
Malfunction of external stoma of urinary tract
50.5
8.7
10
*
KH1AD
NOMESCO Finland
CT of urinary organs
3.7
8.6
36
100
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.8
8.6
35
95
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
7.0
8.6
20
29
KFC00
NOMESCO Finland
Unilateral orchiectomy
27.8
8.5
11
*
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
27.8
8.5
11
*
JN4BD
NOMESCO Finland
Extensive body CT
2.2
8.5
85
405
R35
ICD-10 Finland
Polyuria
2.7
8.4
57
222
Y96.9
ICD-10 Finland
Unspecified type of accident
6.3
8.4
21
34
N06AX11
ATC
mirtazapine; oral
1.6
8.3
244
1689
R10.2
ICD-10 Finland
Pelvic and perineal pain
4.8
8.3
26
55
U04
ICPC
Incontinence urine
3.0
8.3
47
163
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.1
8.3
95
482
H02AB04
ATC
methylprednisolone; systemic
1.9
8.3
124
699
WX400
NOMESCO Finland
Inhalation anesthesy
3.2
8.2
42
137
TKD00
NOMESCO Finland
Dilatation of urethra
7.6
8.2
18
24
WX704
NOMESCO Finland
Intubation
2.6
8.2
57
227
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
8.1
218
1473
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.1
8.1
43
144
G04BD09
ATC
trospium; oral
3.7
8.1
34
95
R06.0
ICD-10 Finland
Dyspnoea
1.7
8.1
192
1251
KC1AE
NOMESCO Finland
Percutaneous ultrasound examination of urinary bladder
33.7
8.1
10
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.5
8.1
36
106
SPAT1254
SPAT
Administration of medicine
1.9
8.1
115
635
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.0
8.0
44
151
NF1AA
NOMESCO Finland
Hip X-ray examination
2.4
8.0
68
301
N18.8
ICD-10 Finland
Other chronic renal failure
3.9
8.0
31
81
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.4
8.0
67
293
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
8.0
340
2578
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
2.0
7.9
101
535
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
6.7
7.9
19
29
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
13.2
7.9
13
10
LEF54
NOMESCO Finland
Repair of apical defect with mesh
13.2
7.9
13
10
M03BX01
ATC
baclofen; systemic
5.5
7.9
22
41
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
7.8
223
1531
Z30.5
ICD-10 Finland
Surveillance of (intrauterine) contraceptive device
2.4
7.8
66
291
Z49.0
ICD-10 Finland
Preparatory care for dialysis
9.5
7.8
15
16
R53
ICD-10 Finland
Malaise and fatigue
1.7
7.8
169
1075
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.2
7.8
39
126
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
7.8
325
2448
R39.1
ICD-10 Finland
Other difficulties with micturition
3.8
7.7
31
84
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
7.5
7.7
17
23
SPAT1255
SPAT
Intravenous administration of medicine
2.6
7.7
53
210
J01DA01
ATC
[U] cefalexin; systemic
1.5
7.6
492
4075
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.1
7.6
88
447
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
3.5
7.6
33
96
H02AB06
ATC
prednisolone; systemic
1.5
7.5
356
2753
Z30.2
ICD-10 Finland
Sterilization
2.1
7.5
86
437
LEF13
NOMESCO Finland
Colpoperineoplasty and vaginal hysterectomy
3.8
7.5
30
81
N06AX16
ATC
venlafaxine; oral
1.9
7.5
105
574
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.0
7.5
41
141
Z46.6
ICD-10 Finland
Fitting and adjustment of urinary device
80.8
7.4
8
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
7.4
170
1098
B05DB
ATC
Hypertonic solutions
13.5
7.4
12
9
KCW96
NOMESCO Finland
Other operations on bladder
8.5
7.3
15
18
Z93.6
ICD-10 Finland
Other artificial openings of urinary tract status
+∞
7.3
7
*
Y60.8
ICD-10 Finland
Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care during other surgical and medical care
+∞
7.3
7
*
Y88.2
ICD-10 Finland
Sequelae of adverse incidents associated with medical devices in diagnostic and therapeutic use
+∞
7.3
7
*
J02AC01
ATC
fluconazole; systemic
1.5
7.2
331
2532
R2110
NOMESCO Finland
Giving the first information
2.3
7.2
67
308
J01MA06
ATC
norfloxacin; oral
1.8
7.2
119
692
KDE20
NOMESCO Finland
Removal of foreign body from urethra
7.4
7.2
16
22
WX882
NOMESCO Finland
High dependency care
4.5
7.2
24
55
KC1AT
NOMESCO Finland
Puncture of urinary bladder with ultrasound guidance
30.3
7.2
9
*
KDV20
NOMESCO Finland
Submucous urethral injection
30.3
7.2
9
*
R30.0
ICD-10 Finland
Dysuria
3.1
7.2
37
123
E0000UV
ATC
NA
1.5
7.1
303
2280
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
6.7
7.1
17
26
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
8.0
7.1
15
19
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
7.1
183
1218
SPAT1125
SPAT
Stoma care and guidance
6.1
7.1
18
30
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
2.4
7.1
58
250
G01AA10
ATC
clindamycin; vaginal
1.8
7.1
136
832
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
8.9
7.1
14
16
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.9
7.0
41
147
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.1
7.0
76
378
Z3226
NOMESCO Finland
Physiotherapist
1.7
7.0
140
864
A46
ICD-10 Finland
Erysipelas
1.9
7.0
96
524
R03AC02
ATC
salbutamol; inhalant
1.5
7.0
402
3225
A02BC05
ATC
esomeprazole; systemic
1.5
7.0
306
2316
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
7.0
289
2157
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
5.2
7.0
20
39
Z30.0
ICD-10 Finland
General counselling and advice on contraception
2.6
7.0
49
197
N30
ICD-10 Finland
Cystitis
2.2
7.0
68
322
A07AA09
ATC
vancomycin; oral
5.9
6.9
18
31
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
5.9
6.9
18
31
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.9
6.9
21
44
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
8.4
6.8
14
17
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
5.1
6.8
20
40
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.9
6.8
98
543
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
2.1
6.8
80
408
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
9.4
6.8
13
14
KGV30
NOMESCO Finland
Implantation of prosthesis into penis
40.4
6.8
8
*
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
16.9
6.8
10
6
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
16.9
6.8
10
6
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
6.8
101
567
B03XA02
ATC
darbepoetin alfa; parenteral
4.8
6.7
21
45
TQW40
NOMESCO Finland
Remowal of suture of skin
2.5
6.7
53
224
N05BA04
ATC
oxazepam; oral
1.6
6.7
196
1346
JAH00
NOMESCO Finland
Laparotomy
3.9
6.7
26
69
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
6.7
523
4449
RF210
NOMESCO Finland
NA
3.7
6.6
27
75
UKD02
NOMESCO Finland
Urethroscopy
12.4
6.6
11
9
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.5
6.6
50
210
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.2
6.5
32
103
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.2
6.5
65
312
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
6.5
258
1907
E87.6
ICD-10 Finland
Hypokalaemia
4.3
6.5
22
52
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.5
6.4
405
3289
Y60.9
ICD-10 Finland
Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care during unspecified surgical and medical care
70.4
6.4
7
*
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.5
6.4
311
2392
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
14.4
6.4
10
7
SPAT1216
SPAT
Assessment of functional ability
1.8
6.4
117
701
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.8
6.3
38
140
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
5.6
6.3
17
31
KED33
NOMESCO Finland
Transurethral incision of prostate
5.6
6.3
17
31
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
6.3
149
964
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.2
6.3
61
287
Z49.2
ICD-10 Finland
Other dialysis
9.3
6.3
12
13
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.2
6.3
61
288
TJF80
NOMESCO Finland
Ostomy education
18.2
6.3
9
5
LWA00
NOMESCO Finland
Repair of wound dehiscence in gynaecological surgery
+∞
6.3
6
*
Y76
ICD-10 Finland
Obstetric and gynaecological devices associated with adverse incidents
+∞
6.3
6
*
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
+∞
6.3
6
*
KCF00
NOMESCO Finland
Cystotomy and removal of foreign body from bladder
+∞
6.3
6
*
Y83.0
ICD-10 Finland
Surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
+∞
6.3
6
*
T84.1
ICD-10 Finland
Mechanical complication of internal fixation device of bones of limb
+∞
6.3
6
*
N99.9
ICD-10 Finland
Postprocedural disorder of genitourinary system, unspecified
26.9
6.2
8
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
7.1
6.2
14
20
D64.9
ICD-10 Finland
Anaemia, unspecified
2.0
6.2
76
397
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.7
6.2
128
797
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
6.2
128
798
C07AB07
ATC
bisoprolol; oral
1.4
6.1
344
2723
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.4
6.1
388
3145
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.2
6.1
58
274
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
6.1
197
1384
B05DA
ATC
Isotonic solutions
8.7
6.1
12
14
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.5
6.1
26
76
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
6.8
6.1
14
21
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
6.0
122
755
Z00.0
ICD-10 Finland
General medical examination
1.7
6.0
136
870
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
5.2
6.0
17
33
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
6.0
158
1055
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
4.6
6.0
19
42
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.0
6.0
32
110
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026008) Bacteria identified in Urine by Culture
434
2286
2.70
47.10
7.5
2.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
353
1766
2.62
41.33
7.7
3.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
527
3314
2.38
35.89
5.6
3.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
688
4896
2.61
35.21
10.3
4.2
e6/l
5486.1
2855.7
0.36
21
75
(3044640) Blood type and Crossmatch panel - Blood
391
2191
2.37
34.36
3.4
2.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
201
822
2.85
34.21
2.9
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
134
465
3.20
30.30
2.2
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
362
2096
2.20
28.06
7.7
3.0
e6/l
163.8
108.5
0.39
311
1607
(3000850) Epithelial cells [#/volume] in Urine
279
1468
2.29
27.18
4.6
2.4
e6/l
5.3
6.2
0.58
250
1273
(3037467) Urinalysis macro (dipstick) panel - Urine
683
5110
2.31
26.95
8.8
4.1
—
—
—
0
0
(3026782) Osmolality of Urine
266
1377
2.31
26.89
5.8
2.6
mosm/kgh2o
537.5
546.4
0.29
231
1173
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
367
2205
2.11
25.25
3.0
2.2
u/l
51.9
57.7
2.78
340
2026
(3032080) INR in Blood by Coagulation assay
426
2740
2.03
24.02
12.9
8.7
inr
1.2
1.2
0.45
127
805
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
523
3642
2.01
23.31
6.8
5.6
umol/l
10.1
11.2
2.04
493
3439
(3018095) Leukocytes [#/volume] in Urine
397
2512
2.02
23.22
9.0
3.4
e6/l
152.7
103.4
0.70
320
1743
(3007853) Bacteria identified in Skin by Aerobe culture
162
714
2.54
23.11
2.4
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
83
260
3.41
21.98
3.1
2.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
501
3493
1.95
21.62
12.0
5.6
mmol/l
1.2
1.2
1.42
422
2926
(3013826) Glucose [Moles/volume] in Serum or Plasma
565
4105
1.98
21.57
7.1
4.1
mmol/l
6.7
6.6
0.60
533
3802
(3022948) Iron [Moles/volume] in Serum or Plasma
214
1099
2.23
21.47
3.6
2.1
umol/l
11.2
13.2
4.62
190
1007
(3020779) Urea [Moles/volume] in Serum or Plasma
127
517
2.69
21.21
11.7
6.2
mmol/l
11.8
9.7
2.52
117
491
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
214
1106
2.22
21.10
2.4
1.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
466
3193
1.93
20.95
10.0
4.9
mmol/l
1.2
1.2
0.92
432
2847
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
285
1670
2.02
20.07
3.3
2.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
478
3339
1.90
19.91
7.1
5.1
%
2.9
2.8
0.11
444
3103
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
205
1066
2.19
19.78
7.9
2.7
e6/l
3.1
3.0
0.06
150
590
(42870588) Differential panel, method unspecified - Blood
362
2314
1.93
19.74
6.9
5.1
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
488
3440
1.89
19.67
7.1
5.3
%
26.2
28.2
3.99
454
3194
(3019069) Monocytes/100 leukocytes in Blood
478
3350
1.89
19.59
7.5
5.4
%
8.4
8.4
0.08
446
3131
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
75
237
3.36
19.56
2.1
1.9
ug/l
9.2
1.6
0.72
56
210
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
186
934
2.24
19.54
4.0
2.2
%
21.1
22.6
0.66
154
791
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
702
5599
2.07
19.40
10.2
6.6
u/l
83.1
77.2
0.51
671
5225
(3018010) Neutrophils/100 leukocytes in Blood
480
3401
1.86
18.69
7.1
5.0
%
59.1
57.2
3.20
445
3177
(3022096) Basophils/100 leukocytes in Blood
462
3238
1.86
18.60
7.2
5.2
%
0.6
0.7
0.69
428
3009
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
63
185
3.58
18.39
3.6
2.5
u/ml
0.3
0.4
0.52
36
100
(3024561) Albumin [Mass/volume] in Serum or Plasma
435
3008
1.85
18.14
6.6
4.1
g/l
34.2
35.6
4.96
401
2777
(3030467) Casts [#/volume] in Urine by Automated count
308
1917
1.91
17.81
7.4
2.9
e6/l
0.3
0.4
1.92
260
1445
(3004789) Transferrin [Mass/volume] in Serum or Plasma
191
1005
2.14
17.71
3.9
2.1
g/l
2.2
2.3
2.42
173
925
(3002032) Base excess in Venous blood by calculation
129
580
2.42
17.39
6.6
3.0
mmol/l
1.6
2.0
0.66
110
446
(36304419) Bacteria [Presence] in Urine
299
1868
1.89
16.94
7.2
2.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
157
777
2.23
16.92
2.8
2.3
%
1.9
1.8
0.60
143
685
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
60
181
3.48
16.82
1.5
1.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
503
3698
1.80
16.59
7.3
5.3
e9/l
0.2
0.2
0.14
456
3277
(3006315) Basophils [#/volume] in Blood
488
3565
1.79
16.36
6.8
5.1
e9/l
0.0
0.0
0.08
440
3112
(3019198) Lymphocytes [#/volume] in Blood
496
3650
1.78
16.14
6.9
5.1
e9/l
1.7
1.9
3.80
445
3239
(3003458) Phosphate [Moles/volume] in Serum or Plasma
165
854
2.14
15.83
11.3
4.3
mmol/l
1.1
1.0
1.62
153
769
(3009261) Glucose [Presence] in Urine by Test strip
493
3639
1.77
15.71
6.7
3.5
estimate
0.0
0.0
0.80
100
683
(3021601) Nitrite [Presence] in Urine by Test strip
487
3596
1.75
15.37
8.6
4.7
estimate
0.0
0.0
0.50
103
701
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
200
1125
1.99
15.27
6.7
2.6
e6/l
1.7
1.1
0.91
144
643
(3001604) Monocytes [#/volume] in Blood
481
3545
1.75
15.23
6.8
5.1
e9/l
0.6
0.6
1.08
435
3089
(3022217) INR in Platelet poor plasma by Coagulation assay
165
873
2.08
14.88
22.4
22.9
inr
1.3
1.2
0.37
30
104
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
419
2984
1.74
14.87
2.3
2.0
pmol/l
92.1
95.9
0.77
229
1529
(3023520) Reticulocytes [#/volume] in Blood
120
559
2.32
14.85
3.0
2.4
e9/l
68.7
69.1
0.04
93
434
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
835
7348
2.49
14.84
29.6
12.3
mg/l
23.5
22.6
0.39
738
5688
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
98
417
2.51
14.81
1.8
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
101
437
2.47
14.73
5.2
3.4
ph
7.4
7.4
1.77
12
50
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
101
440
2.46
14.52
5.3
3.4
kpa
5.1
5.2
1.05
95
412
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
97
415
2.50
14.49
5.2
3.4
mmol/l
2.2
2.1
0.06
74
314
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
309
2033
1.78
14.34
3.3
2.9
ng/l
1966.3
1202.7
1.40
257
1718
(3035350) Ketones [Presence] in Urine by Test strip
479
3583
1.70
13.89
6.6
3.5
estimate
0.0
0.0
0.00
103
692
(3012095) Magnesium [Moles/volume] in Serum or Plasma
185
1044
1.97
13.88
3.9
2.7
mmol/l
0.8
0.8
1.47
167
956
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
30
62
4.97
13.87
1.9
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
148
772
2.09
13.81
2.1
1.7
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
40
105
3.94
13.72
6.2
6.0
iu/ml
164.4
428.3
—
7
16
(3000991) Gas panel - Venous blood
108
505
2.29
13.21
12.2
6.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
141
736
2.08
13.10
9.0
6.2
mmol/l
0.6
1.2
0.77
109
567
(3013650) Neutrophils [#/volume] in Blood by Automated count
534
4155
1.68
12.99
11.0
7.9
e9/l
4.3
4.0
1.86
477
3651
(3019225) pH of Specimen
135
696
2.10
12.95
6.3
3.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
47
145
3.36
12.74
1.8
1.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
661
5468
1.74
12.59
5.1
3.9
mm/h
15.3
12.2
3.73
611
5026
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
34
85
4.12
12.46
3.3
2.7
—
927.4
—
0
5
(3016502) Oxygen saturation in Arterial blood
126
644
2.11
12.34
9.4
6.6
%
96.4
95.4
1.97
121
618
(3013512) EKG study
307
2090
1.70
12.24
4.7
3.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
284
1900
1.72
12.04
2.5
2.0
mg/l
2.8
3.0
0.64
244
1602
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
143
777
2.00
11.84
2.2
1.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
306
2097
1.69
11.82
2.4
2.0
u/l
388.1
265.7
0.25
290
1966
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
88
397
2.35
11.68
2.2
1.5
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
137
739
2.00
11.57
9.2
6.2
kpa
5.0
5.1
0.23
130
699
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
117
596
2.10
11.54
2.3
2.0
g/l
0.2
0.2
0.32
106
560
(3027801) Oxygen [Partial pressure] in Arterial blood
136
739
1.99
11.24
9.2
6.2
kpa
12.1
12.2
0.09
128
701
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
410
3061
1.61
11.12
2.5
2.2
nmol/l
77.2
77.9
0.18
370
2736
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
322
2265
1.65
11.11
3.8
3.0
u/l
30.5
31.2
0.09
305
2159
(3001122) Ferritin [Mass/volume] in Serum or Plasma
448
3421
1.60
11.03
3.7
2.6
ug/l
136.3
107.9
1.78
418
3149
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
247
1625
1.71
10.97
1.9
1.6
mg/l
1.1
1.1
0.01
196
1225
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
369
2701
1.61
10.76
4.9
3.4
ng/l
208.3
49.1
0.43
253
1791
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
16
23
7.06
10.60
1.2
2.7
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
44
147
3.09
10.51
1.5
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
44
147
3.09
10.51
1.5
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
582
4763
1.61
10.46
3.8
2.8
u/l
45.8
42.9
0.42
539
4433
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
64
263
2.54
10.40
2.5
1.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
72
314
2.40
10.31
5.8
3.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
34
5.69
10.25
1.1
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
125
682
1.96
10.17
4.8
3.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
66
282
2.44
9.88
2.7
1.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
569
4664
1.58
9.88
3.6
3.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
23
51
4.60
9.81
1.1
2.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
833
7562
2.09
9.78
31.6
14.1
mmol/l
139.3
139.7
5.42
814
7336
(40768804) Tissue Pathology biopsy report
399
3023
1.57
9.78
2.4
2.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
208
1354
1.69
9.44
4.9
3.4
ng/l
159.4
408.3
1.68
155
1020
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
128
724
1.89
9.34
4.3
3.7
u/l
226.7
250.7
1.05
116
681
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
72
329
2.29
9.28
11.4
8.0
mmol/l
24.1
24.5
0.43
66
302
(3017143) Hepatitis C virus Ab [Presence] in Serum
129
733
1.88
9.28
2.0
1.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
832
7588
2.02
9.04
32.1
14.2
mmol/l
4.0
4.0
0.56
811
7348
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
102
540
2.00
9.03
6.9
3.3
ng/l
140.9
79.0
2.99
89
475
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
31
5.57
9.00
1.1
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
70
323
2.26
8.82
8.4
8.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
64
285
2.34
8.76
2.9
2.1
u/l
236.2
2520.6
2.62
22
119
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
45
169
2.75
8.76
1.4
1.3
mg/l
685.0
452.6
0.58
45
156
(1616796) Gas panel - Central venous blood
38
133
2.94
8.41
3.6
3.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
55
233
2.45
8.41
5.0
2.9
g/l
0.2
0.3
0.10
27
75
(3018418) pH of Serum or Plasma
290
2102
1.55
8.35
7.1
3.4
ph
7.4
7.4
0.42
61
391
(3021960) Folate [Moles/volume] in Serum or Plasma
249
1754
1.58
8.09
1.8
1.5
nmol/l
20.9
21.2
0.11
214
1470
(3048689) Calprotectin [Mass/mass] in Stool
144
884
1.75
7.99
1.9
2.1
ug/g
148.6
113.9
0.37
109
690
(40758558) Short blood count panel - Blood
253
1797
1.56
7.90
8.5
6.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
25
70
3.64
7.89
1.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
26
75
3.54
7.86
1.1
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
40
150
2.74
7.83
1.7
1.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
40
151
2.72
7.73
1.4
1.4
e6/l
40.6
25.9
0.17
33
120
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
64
307
2.17
7.37
2.0
1.8
g/l
1.9
1.6
1.59
56
267
(3037522) Nuclear Ab [Titer] in Serum
151
960
1.69
7.36
1.4
1.3
titre
618.2
515.7
0.24
33
205
(3020682) Albumin/Creatinine [Ratio] in Urine
290
2151
1.51
7.33
4.8
4.0
mg/mmol
11.2
8.1
0.79
193
1334
(3009508) Creatinine [Moles/volume] in Urine
291
2163
1.51
7.27
3.8
3.1
mmol/l
6.6
7.2
1.73
249
1806
(3026493) Urate [Moles/volume] in Serum or Plasma
247
1779
1.53
7.14
3.3
2.4
umol/l
7891.9
6648.4
0.12
217
1518
(3024928) Oxygen saturation in Venous blood
38
147
2.65
7.03
3.9
2.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
198
1362
1.58
7.01
2.0
1.7
nmol/l
975.5
1193.3
2.73
151
1003
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
14
27
5.25
6.98
1.2
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
766
6944
1.62
6.82
24.7
11.4
ml/min/173m2
78.2
80.8
2.18
657
5644
(3017732) Neutrophils [#/volume] in Blood
88
490
1.88
6.72
2.9
2.8
e9/l
4.0
3.8
0.37
68
378
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
27
90
3.06
6.54
1.9
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
16
37
4.38
6.51
1.9
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
16
37
4.38
6.51
1.9
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
271
2025
1.48
6.47
6.5
3.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
21
60
3.56
6.46
1.6
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
45
197
2.35
6.45
3.4
3.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
27
91
3.03
6.42
1.8
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
27
91
3.03
6.42
1.9
1.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
42
179
2.41
6.39
3.3
2.6
mmol/l
24.7
25.2
0.26
34
158
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
5
18.16
6.27
3.0
5.0
—
—
—
0
0
(3002256) Pathology report gross observation
142
927
1.63
6.21
1.4
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
26
88
3.01
6.15
1.9
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
26
88
3.01
6.15
1.9
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
33
128
2.64
6.10
1.4
1.5
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
10
8
12.62
6.09
1.1
1.4
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
43
190
2.33
6.05
1.8
1.8
%
93.8
91.3
0.41
43
177
(3005988) Vibrio sp identified in Specimen by Organism specific culture
26
89
2.98
6.04
1.9
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
33
129
2.62
6.01
2.5
2.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
270
2043
1.46
5.97
3.9
3.2
mg/l
280.0
184.7
0.17
190
1269
(3011397) Hemoglobin [Presence] in Urine by Test strip
223
1628
1.49
5.91
5.8
3.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
122
776
1.66
5.90
2.7
2.5
umol/l
7.8
8.1
0.06
103
680
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
158
1074
1.57
5.83
2.0
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
46
213
2.22
5.82
1.3
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
352
2812
1.41
5.72
7.3
3.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
827
7724
1.71
5.60
26.3
11.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
319
2516
1.41
5.54
3.4
3.2
mmol/l
2.3
2.4
0.46
265
2170
(3019060) Gas panel - Arterial blood
74
416
1.85
5.51
5.8
4.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
834
7816
1.72
5.46
14.4
9.5
u/l
23.8
24.4
0.63
803
7519
(3022145) Colonoscopy Study observation
120
776
1.63
5.44
1.4
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
93
563
1.73
5.41
2.0
2.5
g/l
65.2
66.8
1.05
84
512
(3006184) Hemoglobin [Mass/volume] in Capillary blood
36
155
2.38
5.39
2.7
2.0
g/l
130.8
128.2
0.25
30
118
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
41
187
2.25
5.39
1.2
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
96
587
1.71
5.38
1.2
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
136
909
1.58
5.38
4.9
4.4
%
33.0
32.8
0.06
100
591
(40768797) Stomach Pathology biopsy report
146
992
1.56
5.38
1.2
1.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
28
107
2.67
5.35
1.3
1.3
mmol/l
60.0
66.5
0.42
22
92
(3023410) Appearance of Cerebral spinal fluid
20
64
3.17
5.21
1.8
1.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
20
64
3.17
5.21
1.1
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
92
564
1.70
5.12
2.7
2.4
ug/l
5.1
6.8
0.60
70
487
(46235355) HIV 1 and 2 tests - Meaningful Use set
180
1295
1.48
5.07
2.1
1.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
19
60
3.21
5.06
1.6
2.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
194
1417
1.47
5.06
1.5
1.4
g/l
2.4
2.4
0.18
119
857
(40768446) Kidney Pathology biopsy report
10
19
5.31
5.05
2.8
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
753
6925
1.48
4.99
5.6
4.9
mu/l
1.9
2.1
0.48
694
6318
(3036489) Thrombin time
48
241
2.05
4.98
1.8
1.7
s
20.8
20.8
0.03
42
217
(3029937) Albumin [Presence] in Urine by Test strip
252
1940
1.41
4.94
7.8
3.8
estimate
0.0
0.0
0.88
96
681
(3051611) Lipemic interference index of Serum or Plasma
19
61
3.16
4.93
3.2
3.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
97
611
1.66
4.88
4.1
2.2
u/l
29.6
34.8
0.90
77
520
(3004616) Nuclear Ab [Presence] in Serum
24
89
2.74
4.87
1.2
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
54
286
1.94
4.84
6.1
3.2
%
51.0
46.9
0.48
54
281
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
26
101
2.62
4.84
2.4
1.3
u/ml
122.3
119.6
—
7
19
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
34
151
2.30
4.78
1.5
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
35
158
2.26
4.74
1.5
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
382
3165
1.35
4.73
14.0
8.3
e9/l
0.0
0.0
0.18
316
2615
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
20
69
2.94
4.62
1.6
1.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
68
394
1.78
4.62
1.4
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
28
116
2.46
4.59
2.5
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
862
8210
1.81
4.56
39.4
18.5
e9/l
255.8
252.7
0.75
848
7996
(3024731) MCV [Entitic volume]
862
8211
1.80
4.54
39.3
18.4
fl
91.1
91.0
0.20
850
8081
(3035941) MCH [Entitic mass]
862
8213
1.80
4.51
39.2
18.4
pg
30.2
30.2
0.79
850
8082
(3051651) Icteric interference index of Serum or Plasma
14
39
3.63
4.50
3.4
3.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
862
8214
1.80
4.49
39.4
18.5
e12/l
4.3
4.5
8.82
845
7973
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
732
6734
1.43
4.49
6.6
5.6
mmol/mol
40.0
39.6
0.54
684
6212
(3000963) Hemoglobin [Mass/volume] in Blood
862
8216
1.79
4.46
39.8
18.6
g/l
129.8
133.9
13.75
852
8083
(3010813) Leukocytes [#/volume] in Blood
862
8216
1.79
4.46
39.5
18.5
e9/l
7.0
6.6
4.31
845
7975
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
648
5849
1.37
4.39
4.6
4.1
pmol/l
14.6
14.7
0.38
589
5327
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
122
836
1.53
4.32
2.0
2.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
7
6
11.74
4.28
7.7
8.0
mmol/l
5.8
5.2
—
7
6
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
216
1666
1.39
4.10
1.4
1.2
u/ml
2.8
1.5
0.64
53
440
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
12
32
3.79
4.09
2.2
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
12
32
3.79
4.09
2.2
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
78
487
1.66
4.08
2.4
2.9
g/l
10.3
10.5
0.23
70
450
(3019150) Specific gravity of Urine by Refractometry
206
1578
1.39
4.07
7.1
3.8
kg/l
1.0
1.0
0.08
33
229
(3019230) Fractional oxyhemoglobin in Venous blood
26
111
2.38
4.02
3.9
1.6
%
62.4
58.9
0.35
26
111
(40761536) Microorganisms panel - Urine sediment
95
626
1.58
4.00
7.7
3.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
16
53
3.05
3.98
1.3
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
765
7138
1.43
3.94
5.2
4.4
mmol/l
6.0
5.9
1.45
703
6460
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
37
185
2.04
3.93
1.8
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
55
315
1.79
3.92
2.3
1.8
—
—
—
0
0
(4024509)
17
59
2.92
3.91
1.5
1.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
64
384
1.72
3.89
1.8
1.8
g/l
1.3
1.4
0.29
59
356
(3044889) 12 lead EKG panel
568
5071
1.31
3.88
4.1
3.6
—
—
—
0
0
(3012501) Base excess in Blood by calculation
29
133
2.22
3.83
4.0
3.6
mmol/l
2.7
2.8
0.05
21
87
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
7
8
8.81
3.77
1.0
1.6
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
6
5
12.07
3.76
1.0
1.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
22
90
2.48
3.74
1.1
1.2
u/ml
3.2
1.8
—
9
24
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
45
246
1.87
3.72
1.9
1.9
g/l
10.5
10.6
0.04
32
213
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
8
12
6.71
3.68
1.5
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
77
496
1.60
3.58
4.4
2.7
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
33
164
2.05
3.58
4.2
3.6
mg/l
14.5
25.5
1.48
20
102
(3009542) Hematocrit [Volume Fraction] of Blood
726
6745
1.36
3.58
27.4
13.5
%
38.3
39.4
2.47
505
4839
(3045424) Erythrocytes [Presence] in Urine
25
111
2.29
3.57
1.6
1.3
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
7
9
7.83
3.56
1.0
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
173
1315
1.39
3.56
1.3
1.3
iu/ml
19.2
30.9
2.08
58
435
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
108
753
1.49
3.53
1.9
1.8
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
8
13
6.20
3.50
9.1
3.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
28
132
2.16
3.48
2.7
2.3
%
16.3
16.1
0.08
20
71
(3004588) Protein electrophoresis panel - Serum or Plasma
75
484
1.60
3.47
2.0
2.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
267
1.80
3.46
1.8
1.9
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
267
1.80
3.46
1.8
1.9
g/l
7.4
7.4
0.01
30
203
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
267
1.80
3.46
1.8
1.9
g/l
4.0
3.8
0.62
30
194
(3011648) Oxygen content in Venous blood
14
47
3.01
3.42
4.1
1.6
%
10.1
10.5
0.15
14
47
(40761535) Cells panel - Urine sediment
86
576
1.54
3.40
6.5
3.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
20
82
2.47
3.40
1.7
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
11
32
3.47
3.34
1.5
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
81
538
1.55
3.33
4.0
4.2
%
0.1
0.1
0.21
30
138
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
783
7391
1.40
3.28
5.0
4.8
mmol/l
2.7
2.8
2.16
720
6771
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
25
116
2.19
3.25
1.6
1.8
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
16
60
2.70
3.24
1.2
1.1
—
79.0
—
0
6
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
251
1.79
3.22
1.9
1.9
g/l
3.4
3.1
1.07
30
198
(3033799) Differential panel - Peritoneal fluid
8
15
5.37
3.19
1.9
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
174
1347
1.36
3.19
1.7
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
76
503
1.56
3.18
3.8
4.0
%
0.5
0.5
0.08
22
107
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
16
61
2.65
3.14
2.1
1.4
%
53.3
59.6
—
10
38
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
17
67
2.57
3.14
1.3
1.3
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
11
34
3.26
3.06
1.3
1.2
ratio
1.0
1.1
—
6
12
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
16
5.03
3.05
1.0
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
71
468
1.56
3.03
1.9
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
82
559
1.51
3.01
4.0
4.1
%
0.6
0.9
0.60
31
150
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
38
212
1.83
3.00
3.1
3.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
84
577
1.50
2.98
5.4
3.3
mmol/l
1.2
1.2
0.78
72
490
(3024980) IgG subclass 4 [Mass/volume] in Serum
20
88
2.30
2.95
1.6
1.2
g/l
0.8
0.8
0.02
14
69
(40768443) Skin Pathology biopsy report
53
328
1.65
2.93
1.2
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
59
376
1.61
2.91
2.7
2.4
—
—
—
0
0
(44806118)
17
70
2.46
2.89
1.4
1.5
—
—
—
0
0
(44790048)
17
70
2.46
2.89
1.4
1.5
—
—
—
0
0
(44790047)
17
70
2.46
2.89
1.4
1.5
—
—
—
0
0
(44790049)
17
70
2.46
2.89
1.4
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
199
1595
1.32
2.87
1.8
1.7
pmol/l
135758001.6
30781331.3
0.55
165
1319
(3024471) HLA-A [Type]
7
13
5.42
2.87
1.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
13
5.42
2.87
1.1
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
7
13
5.42
2.87
1.1
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
38
217
1.78
2.80
2.0
2.0
g/l
38.0
37.5
0.19
28
186
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
8
18
4.47
2.80
1.0
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
19
84
2.29
2.78
1.7
1.6
pg
33.7
32.3
0.86
19
84
(3000475) Leukocytes [#/volume] in Synovial fluid
25
124
2.04
2.78
2.1
1.4
e6/l
22383.6
9692.8
0.53
18
94
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
36
203
1.80
2.77
3.2
3.1
mg/l
51.5
43.4
0.19
29
159
(3034860) Kappa light chains.free [Mass/volume] in Serum
36
203
1.80
2.77
3.2
3.1
mg/l
65.9
73.2
0.08
29
160
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
33
182
1.84
2.72
1.0
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
10
6.03
2.70
1.2
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
37
3.00
2.70
1.2
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
20
92
2.20
2.68
1.1
1.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
74
507
1.50
2.68
4.2
4.2
%
0.0
0.9
0.62
27
119
(4035726)
85
599
1.46
2.68
1.3
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
19
86
2.23
2.65
1.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
19
86
2.23
2.65
2.3
1.8
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
98
711
1.42
2.65
4.3
4.0
ug/l
5.3
26.3
1.14
74
576
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
25
127
2.00
2.62
2.0
3.7
%
60.0
58.9
0.18
25
127
(3016650) Hepatitis A virus Ab [Presence] in Serum
20
93
2.18
2.62
1.1
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
17
74
2.32
2.59
2.6
2.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
22
107
2.08
2.59
1.1
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
25
3.62
2.58
1.1
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
25
128
1.98
2.57
1.6
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
25
128
1.98
2.57
5.1
2.6
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
8
20
4.03
2.57
1.0
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
20
4.03
2.57
1.0
1.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
39
231
1.72
2.56
2.2
2.1
g/l
0.1
0.7
1.88
29
201
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
159
1255
1.32
2.55
1.3
1.3
u/ml
10.0
12.9
0.20
50
491
(3035637) Corticotropin [Mass/volume] in Plasma
15
62
2.44
2.55
1.3
1.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
15
62
2.44
2.55
1.6
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
24
122
1.99
2.52
2.0
3.5
e9/l
4.6
4.6
0.08
24
122
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
7
16
4.40
2.48
1.7
3.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
17
76
2.26
2.45
1.4
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
28
152
1.87
2.45
2.1
3.3
—
—
—
0
0
(4306422)
18
83
2.19
2.42
1.1
1.2
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
10
34
2.96
2.41
1.2
1.1
u/l
331.8
346.4
—
10
29
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
12
5.02
2.40
1.2
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
17
77
2.23
2.38
1.4
1.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
21
104
2.04
2.37
1.5
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
12
46
2.63
2.36
1.5
2.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
240
2017
1.26
2.36
1.6
1.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
7
17
4.14
2.36
1.1
2.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
47
300
1.60
2.35
2.0
2.2
u/l
42.1
39.2
0.39
42
262
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
55
365
1.54
2.33
2.4
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
105
2.02
2.32
1.4
1.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
9
28
3.24
2.31
2.1
12.8
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
12
47
2.57
2.27
1.4
1.8
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
207
1717
1.27
2.27
6.1
5.1
ug/l
4.6
3.5
0.34
185
1511
(3034770) Mitochondria Ab [Titer] in Serum
30
171
1.78
2.27
1.1
1.2
—
1137.0
—
0
10
(3037756) Immunofixation for Serum or Plasma
27
149
1.84
2.26
1.6
1.7
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
18
3.91
2.25
1.0
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
14
60
2.35
2.22
1.6
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
20
100
2.02
2.22
1.1
1.2
u/ml
4.3
6.1
0.29
11
41
(40760892) CBC W Ordered Manual Differential panel - Blood
193
1594
1.27
2.19
4.9
4.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
41
631
0.63
2.19
1.6
1.7
—
—
—
0
0
(4268621)
14
61
2.32
2.15
1.9
2.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
6
14
4.31
2.15
2.2
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
58
397
1.49
2.15
1.1
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
76
550
1.42
2.12
1.2
1.2
iu/ml
121.8
147.0
0.33
27
230
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
19
95
2.02
2.11
1.3
1.6
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
10
37
2.72
2.11
3.5
2.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
168
1372
1.27
2.09
2.5
2.8
mmol/l
2.4
2.4
0.01
135
1203
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
75
543
1.42
2.09
5.3
2.5
ml/min/173m2
53.0
66.5
2.44
42
219
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
17
82
2.09
2.07
1.4
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
31
2.92
2.07
1.1
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
9
31
2.92
2.07
4.3
2.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
657
6173
1.23
2.07
32.0
15.1
%
13.9
13.7
2.75
647
6041
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
20
3.52
2.06
1.9
3.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
20
3.52
2.06
1.0
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
15
4.02
2.04
1.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
22
118
1.89
2.03
1.6
1.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
27
155
1.76
2.02
2.2
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
18
90
2.02
2.01
1.3
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
19
97
1.98
2.01
2.3
2.7
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
21
3.35
1.96
1.0
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
7
21
3.35
1.96
1.0
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
759
7257
1.26
1.96
4.6
4.3
mmol/l
4.6
4.7
2.68
704
6694
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
11
4.56
1.94
1.0
1.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
107
834
1.32
1.90
1.7
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
730
6956
1.24
1.90
4.2
3.8
mmol/l
1.3
1.2
0.71
665
6327
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
28
166
1.71
1.89
1.7
1.2
—
—
—
0
0
(4010399)
70
511
1.40
1.88
1.2
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
12
52
2.32
1.88
1.1
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
16
79
2.04
1.86
1.1
1.1
—
—
—
0
0
(4027681)
11
46
2.41
1.85
1.3
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
34
214
1.61
1.85
1.7
1.6
iu/ml
0.6
0.1
—
7
37
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
27
437
0.61
1.82
1.4
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
19
101
1.90
1.81
1.8
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
34
215
1.60
1.81
1.4
1.4
ug/g
257.7
310.7
0.86
22
124
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
15
73
2.07
1.81
1.1
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
12
53
2.28
1.81
1.1
1.2
u/ml
0.1
1.2
—
6
22
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
65
473
1.40
1.79
2.5
1.8
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
60
2.18
1.78
4.8
2.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
753
7216
1.24
1.76
4.6
4.2
mmol/l
1.4
1.5
3.58
692
6608
(3017446) Testosterone [Moles/volume] in Serum or Plasma
52
365
1.45
1.74
2.2
2.1
nmol/l
9.3
11.4
0.76
42
318
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
13
61
2.15
1.72
1.3
1.1
u/l
83.4
50.7
—
7
42
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
13
61
2.15
1.72
1.9
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
13
61
2.15
1.72
1.9
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
13
61
2.15
1.72
1.9
1.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
20
112
1.80
1.65
1.7
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
25
2.81
1.65
2.1
2.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
25
2.81
1.65
2.1
2.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
15
76
1.99
1.65
1.2
1.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
32
2.51
1.60
2.4
2.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
26
2.70
1.58
1.3
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
26
2.70
1.58
2.1
2.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
26
2.70
1.58
1.3
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
17
92
1.86
1.56
1.4
1.6
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
15
78
1.94
1.55
1.8
1.9
%
88.1
89.7
0.24
15
78
(40768806) Pleura Pathology biopsy report
13
64
2.05
1.54
1.6
1.5
—
—
—
0
0
(3020891) Body temperature
36
241
1.51
1.54
7.9
4.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
40
274
1.48
1.54
1.1
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
8
33
2.44
1.54
8.9
2.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
50
358
1.42
1.54
6.9
3.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
15
3.35
1.52
1.2
1.6
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
5
15
3.35
1.52
5.8
3.8
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
15
3.35
1.52
1.0
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
86
1.88
1.51
1.3
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
93
739
1.29
1.47
1.9
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
27
171
1.60
1.47
3.1
2.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
30
195
1.56
1.47
1.4
1.2
u/ml
7.6
2.5
—
7
22
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
34
228
1.51
1.46
1.3
1.3
miu/ml
229.8
270.7
0.24
17
112
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
38
2.38
1.46
1.2
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
64
483
1.35
1.45
1.2
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
28
2.51
1.45
1.0
1.0
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
26
164
1.60
1.44
1.2
1.3
u/l
10.3
12.1
0.28
20
137
(3008757) Leukocyte morphology finding [Identifier] in Blood
14
73
1.93
1.44
2.5
4.7
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
17
95
1.80
1.43
1.8
1.7
mmol/l
1.6
1.6
0.16
17
95
(3018405) Lactate [Moles/volume] in Arterial blood
34
230
1.50
1.41
6.3
3.4
mmol/l
1.3
1.4
0.22
34
224
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
46
2.19
1.40
1.2
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
17
2.95
1.36
1.8
1.1
—
—
—
0
0
(4198724)
5
17
2.95
1.36
3.2
1.8
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
30
200
1.52
1.34
1.4
1.2
u/ml
4.6
5.6
—
7
37
(3010144) Erythrocytes [#/volume] in Synovial fluid
11
55
2.01
1.27
1.9
1.2
e6/l
857840.0
131556.0
—
6
38
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
16
92
1.75
1.25
3.0
2.5
mg/l
24.6
28.0
—
5
26
(3027944) Amphetamines [Presence] in Urine
32
220
1.47
1.25
2.0
1.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
25
2.41
1.24
1.0
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
8
36
2.23
1.24
1.9
1.4
—
—
—
0
0
(4062490)
11
56
1.98
1.22
1.7
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
19
2.64
1.21
1.6
2.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
19
2.64
1.21
1.6
2.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
37
2.17
1.21
2.0
1.9
—
—
—
0
0
(4211845)
8
37
2.17
1.21
8.9
2.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
37
2.17
1.21
2.0
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
37
2.17
1.21
2.0
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
32
222
1.46
1.20
2.0
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
38
2.11
1.18
1.6
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
23
149
1.56
1.18
2.2
1.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
32
223
1.45
1.18
2.0
1.5
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
31
215
1.46
1.17
1.5
1.2
—
30.0
—
0
12
(3016879) Cocaine [Presence] in Urine
30
207
1.46
1.16
2.1
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
32
224
1.44
1.15
2.0
1.5
—
—
—
0
0
(4015189)
5
20
2.51
1.15
2.4
3.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
26
175
1.50
1.14
2.2
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
12
65
1.86
1.13
1.2
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
8
40
2.01
1.12
1.4
1.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
7
31
2.27
1.10
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
7
31
2.27
1.10
1.0
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
7
31
2.27
1.10
1.1
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
14
81
1.74
1.09
1.7
2.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
21
2.39
1.09
1.4
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
13
74
1.77
1.07
1.2
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
46
1.97
1.03
1.1
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
46
1.97
1.03
1.1
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
53
1.90
1.01
1.7
2.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
10
53
1.90
1.01
1.2
1.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
26
181
1.45
0.99
9.2
4.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
49
1.84
0.98
1.0
1.1
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
7
36
1.95
0.97
1.6
1.1
u/l
11.4
32.5
—
7
24
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
7
36
1.95
0.97
1.6
1.1
u/l
72.9
92.1
—
7
25
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
36
1.95
0.97
1.3
1.7
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
31
0.00
0.96
0.0
1.5
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
11
62
1.78
0.94
2.4
2.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
21
304
0.68
0.94
1.5
1.7
mg/l
3.5
3.0
0.15
16
215
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
37
1.90
0.94
2.1
1.9
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
42
1.91
0.88
2.3
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
57
460
1.25
0.87
3.3
3.3
pmol/l
4.5
4.5
0.12
47
403
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
11
64
1.73
0.86
1.6
1.8
mmol/l
7.2
7.3
—
6
36
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
8
44
1.83
0.86
1.3
1.2
u/l
11.1
18.0
—
8
38
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
31
1.94
0.84
1.3
1.1
iu/ml
184.0
118.2
—
6
31
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
213
1936
1.13
0.83
1.7
1.6
mmol/l
1.3
1.3
0.08
184
1638
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
29
214
1.37
0.83
1.5
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
32
1.88
0.82
1.3
1.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
29
215
1.36
0.81
1.5
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
47
1.71
0.80
1.1
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
47
1.71
0.80
1.1
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
33
1.82
0.79
1.0
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
12
187
0.64
0.79
1.5
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
29
217
1.35
0.77
1.5
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
27
0.00
0.77
0.0
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16
107
1.50
0.76
1.4
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
6
34
1.77
0.76
1.5
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
13
83
1.57
0.75
1.4
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
18
125
1.45
0.73
1.1
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
12
183
0.65
0.72
1.3
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
28
211
1.34
0.72
1.4
1.5
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
7
39
1.80
0.72
1.9
2.4
e6/l
299.4
431.7
—
7
33
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
13
84
1.56
0.72
1.2
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
12
182
0.65
0.71
1.3
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
31
239
1.31
0.70
1.7
1.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
13
85
1.54
0.69
2.2
2.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
16
110
1.46
0.68
1.1
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
17
119
1.44
0.67
1.1
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
98
859
1.16
0.67
1.6
1.8
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
13
86
1.52
0.66
2.1
2.2
%
13.1
13.2
0.27
13
86
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
5
29
1.73
0.64
4.6
6.0
—
36.4
—
0
5
(40765096) Chromosome analysis panel by Banding
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
22
0.00
0.59
0.0
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
17
123
1.39
0.58
2.2
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
25
193
1.30
0.58
1.6
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
116
0.60
0.57
1.1
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
8
55
1.46
0.56
1.6
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
25
195
1.29
0.54
1.8
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
38
1.58
0.54
1.8
1.9
—
—
—
0
0
(3000492) Spirometry study
75
657
1.15
0.54
1.3
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
17
125
1.37
0.54
1.1
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
61
1.48
0.53
1.9
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
61
1.48
0.53
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
23
178
1.30
0.53
1.3
1.3
—
—
—
0
0
(4034850)
18
237
0.75
0.52
20.3
8.9
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
22
170
1.30
0.52
1.6
1.2
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
6
40
1.50
0.51
1.7
2.0
—
38.1
—
0
8
(21494434) Karyotype in Bone marrow
9
64
1.41
0.51
1.4
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
149
1370
1.10
0.50
4.4
4.5
%
25.8
21.5
1.89
76
683
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
16
118
1.36
0.50
1.1
1.5
u/l
28.9
25.7
0.13
16
102
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
41
1.47
0.50
1.2
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
6
41
1.47
0.50
1.2
1.4
mmol/l
5.5
6.4
—
6
41
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
12
84
1.43
0.49
1.1
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
84
749
1.13
0.48
2.7
1.6
%
1.6
1.4
0.92
72
656
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
10
68
1.48
0.47
1.1
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
12
165
0.72
0.46
2.0
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
17
221
0.76
0.46
1.2
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
18
231
0.77
0.45
1.6
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
18
231
0.77
0.45
1.6
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
112
1.34
0.45
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
51
1.38
0.44
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
51
1.38
0.44
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
51
1.38
0.44
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
51
1.38
0.44
1.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
51
1.38
0.44
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
51
1.38
0.44
1.0
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
18
230
0.78
0.44
1.6
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
18
230
0.78
0.44
1.6
1.4
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
8
56
1.43
0.42
4.8
1.9
mmol/l
8.4
6.8
—
8
40
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
32
1.57
0.42
1.2
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
10
70
1.43
0.42
1.7
2.1
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
5
33
1.52
0.41
1.2
1.2
—
23.6
—
0
5
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
61
686
0.88
0.40
1.3
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
30
251
1.20
0.39
1.6
1.8
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
35
1.43
0.39
1.8
3.9
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
19
0.00
0.39
0.0
1.1
—
0.6
—
0
12
(3015183) Erythrocyte sedimentation rate
5
36
1.39
0.38
1.0
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
10
72
1.39
0.37
3.4
3.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
154
1444
1.08
0.36
1.6
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
249
2605
0.94
0.35
2.9
2.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
122
0.74
0.35
1.4
1.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
44
1.37
0.34
1.2
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
11
82
1.35
0.34
3.0
1.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
20
164
1.22
0.33
1.4
1.2
—
39.7
—
0
15
(3035285) Chloride [Moles/volume] in Venous blood
11
84
1.31
0.30
5.0
2.4
mmol/l
107.7
105.8
0.74
11
84
(3041354) Potassium [Moles/volume] in Venous blood
11
84
1.31
0.30
5.0
2.4
mmol/l
4.3
4.1
0.64
11
84
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
36
316
1.14
0.29
1.3
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
63
1.27
0.28
1.4
1.1
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
8
64
1.25
0.27
1.0
1.7
—
1.4
—
0
6
(4094501)
22
187
1.18
0.26
1.1
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
8
67
1.20
0.26
1.8
4.4
—
47.7
—
0
22
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
15
123
1.22
0.25
1.7
1.6
nmol/l
48.5
41.8
0.29
15
116
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
33
292
1.13
0.25
1.4
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
77
715
1.08
0.25
1.4
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
30
265
1.14
0.24
1.4
1.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
40
1.25
0.22
1.0
1.7
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
42
1.19
0.21
1.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
10
0.00
0.21
0.0
3.1
—
0.7
—
0
10
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.1
—
1.6
—
0
12
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
13
0.00
0.21
0.0
1.1
—
32.4
—
0
8
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
102
967
1.06
0.20
2.7
3.1
ug/l
1.0
0.8
0.54
74
662
(3035320) C reactive protein [Mass/volume] in Body fluid
6
50
1.20
0.19
1.8
2.1
—
—
—
0
0
(4281824)
10
81
1.24
0.19
1.5
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
53
1.13
0.18
1.0
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
13
109
1.20
0.18
1.2
1.0
u/ml
2.6
2.8
—
5
50
(3033705) Calcium.ionized [Moles/volume] in Venous blood
10
83
1.21
0.15
5.4
2.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
19
170
1.12
0.13
2.6
2.5
ug/min
83.3
107.5
0.24
14
108
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
27
248
1.09
0.13
2.2
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
92
886
1.04
0.12
16.9
6.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
10
87
1.15
0.09
1.4
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
628
6240
1.02
0.09
34.9
16.1
g/l
330.2
331.7
4.06
620
6193
(4146454)
7
65
1.08
0.08
2.0
2.6
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
6
74
0.81
0.07
1.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
15
137
1.10
0.07
1.7
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
86
1.05
0.07
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
39
406
0.96
0.06
1.8
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
47
456
1.03
0.04
1.6
1.7
—
—
—
0
0
(1002224) Polysomnography panel
30
290
1.04
0.03
1.2
1.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
21
201
1.05
0.03
2.2
1.8
iu/l
6.6
5.5
—
9
71
(3004716) Salmonella sp identified in Stool by Organism specific culture
38
390
0.97
0.03
1.6
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
27
276
0.98
0.00
1.9
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
13
126
1.03
0.00
1.2
1.5
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
14
142
0.99
0.00
2.9
3.4
nmol/l
0.7
0.8
—
8
116
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
24
242
0.99
0.00
1.5
1.5
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(44813793)
5
54
0.93
0.00
1.0
1.1
—
—
—
0
0
(40758358) Immune stain study
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
10
100
1.00
0.00
1.3
1.2
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
79
1.01
0.00
1.4
1.1
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
9.1
—
0
7
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
14.5
—
0
6
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
8.6
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.0
—
17.6
—
0
7
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_COMPLICATIO_GENITO_PROSTHET_DEVICES_IMPLANTS_GRAFTS – Complications of genitourinary prosthetic devices, implants and grafts
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).